Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model
- PMID: 29574880
- PMCID: PMC5979781
- DOI: 10.1111/bph.14202
Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model
Abstract
Background and purpose: A non-psychoactive phytocannabinoid, cannabidiol (CBD), shows promising results as an effective potential antiepileptic drug in some forms of refractory epilepsy. To elucidate the mechanisms by which CBD exerts its anti-seizure effects, we investigated its effects at synaptic connections and on the intrinsic membrane properties of hippocampal CA1 pyramidal cells and two major inhibitory interneurons: fast spiking, parvalbumin (PV)-expressing and adapting, cholecystokinin (CCK)-expressing interneurons. We also investigated whether in vivo treatment with CBD altered the fate of CCK and PV interneurons using immunohistochemistry.
Experimental approach: Electrophysiological intracellular whole-cell recordings combined with neuroanatomy were performed in acute brain slices of rat temporal lobe epilepsy in in vivo (induced by kainic acid) and in vitro (induced by Mg2+ -free solution) epileptic seizure models. For immunohistochemistry experiments, CBD was administered in vivo (100 mg·kg-1 ) at zero time and 90 min post status epilepticus, induced with kainic acid.
Key results: Bath application of CBD (10 μM) dampened excitability at unitary synapses between pyramidal cells but enhanced inhibitory synaptic potentials elicited by fast spiking and adapting interneurons at postsynaptic pyramidal cells. Furthermore, CBD restored impaired membrane excitability of PV, CCK and pyramidal cells in a cell type-specific manner. These neuroprotective effects of CBD were corroborated by immunohistochemistry experiments that revealed a significant reduction in atrophy and death of PV- and CCK-expressing interneurons after CBD treatment.
Conclusions and implications: Our data suggest that CBD restores excitability and morphological impairments in epileptic models to pre-epilepsy control levels through multiple mechanisms to reinstate normal network function.
© 2018 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
Figures
Similar articles
-
Reduced Cholecystokinin-Expressing Interneuron Input Contributes to Disinhibition of the Hippocampal CA2 Region in a Mouse Model of Temporal Lobe Epilepsy.J Neurosci. 2023 Oct 11;43(41):6930-6949. doi: 10.1523/JNEUROSCI.2091-22.2023. Epub 2023 Aug 29. J Neurosci. 2023. PMID: 37643861 Free PMC article.
-
Short-term effects of kainic acid on CA1 hippocampal interneurons differentially vulnerable to excitotoxicity.Epilepsia. 2005 Jun;46(6):837-48. doi: 10.1111/j.1528-1167.2005.21404.x. Epilepsia. 2005. PMID: 15946325
-
Vulnerability of cholecystokinin-expressing GABAergic interneurons in the unilateral intrahippocampal kainate mouse model of temporal lobe epilepsy.Exp Neurol. 2021 Aug;342:113724. doi: 10.1016/j.expneurol.2021.113724. Epub 2021 Apr 26. Exp Neurol. 2021. PMID: 33915166 Free PMC article.
-
The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights.Neurosci Biobehav Rev. 2020 Apr;111:166-182. doi: 10.1016/j.neubiorev.2020.01.014. Epub 2020 Jan 16. Neurosci Biobehav Rev. 2020. PMID: 31954723 Review.
-
Selective degeneration and synaptic reorganization of hippocampal interneurons in a chronic model of temporal lobe epilepsy.Adv Neurol. 2006;97:69-76. Adv Neurol. 2006. PMID: 16383116 Review.
Cited by
-
Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.Pharmaceuticals (Basel). 2020 Jul 30;13(8):174. doi: 10.3390/ph13080174. Pharmaceuticals (Basel). 2020. PMID: 32751761 Free PMC article. Review.
-
Reduced Cholecystokinin-Expressing Interneuron Input Contributes to Disinhibition of the Hippocampal CA2 Region in a Mouse Model of Temporal Lobe Epilepsy.J Neurosci. 2023 Oct 11;43(41):6930-6949. doi: 10.1523/JNEUROSCI.2091-22.2023. Epub 2023 Aug 29. J Neurosci. 2023. PMID: 37643861 Free PMC article.
-
Spatial Distribution of Parvalbumin-Positive Fibers in the Mouse Brain and Their Alterations in Mouse Models of Temporal Lobe Epilepsy and Parkinson's Disease.Neurosci Bull. 2023 Nov;39(11):1683-1702. doi: 10.1007/s12264-023-01083-0. Epub 2023 Jul 31. Neurosci Bull. 2023. PMID: 37523099 Free PMC article.
-
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?Pharmaceutics. 2021 Nov 1;13(11):1823. doi: 10.3390/pharmaceutics13111823. Pharmaceutics. 2021. PMID: 34834237 Free PMC article. Review.
-
The Effect of Anti-seizure Medications on the Propagation of Epileptic Activity: A Review.Front Neurol. 2021 May 27;12:674182. doi: 10.3389/fneur.2021.674182. eCollection 2021. Front Neurol. 2021. PMID: 34122318 Free PMC article. Review.
References
-
- Ali AB (2007). Presynaptic Inhibition of GABAA receptor‐mediated unitary IPSPs by cannabinoid receptors at synapses between CCK‐positive interneurons in rat hippocampus. J Neurophysiol 98: 861–869. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
